NDC properties for NDC 9 49502-381
NDC item 49502038102
| NDC 9 | 49502-381 |
|---|---|
| NDC 10 | 49502-381-02 |
| NDC Item | 49502038102 |
| packaging | 2 TRAY in 1 KIT (49502-381-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT (49502-567-06) / 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 2 PACKET in 1 KIT (49502-569-02) / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
NDC item 49502038106
| NDC 9 | 49502-381 |
|---|---|
| NDC 10 | 49502-381-06 |
| NDC Item | 49502038106 |
| BLA | BLA761154 |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
NDC item 49502056706
| NDC 9 | 49502-567 |
|---|---|
| NDC 10 | 49502-567-06 |
| NDC Item | 49502056706 |
| packaging | 1 in 1 TRAY |
| packaging | 2 in 1 KIT |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
NDC item 83257001642
| NDC 9 | 83257-016 |
|---|---|
| NDC 10 | 83257-016-42 |
| NDC Item | 83257001642 |
| packaging | 2 TRAY in 1 KIT (83257-016-42) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 789322 |
| Labeler | Biocon Biologics Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-30 |
| Marketing status | ACTIVE |